Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report

Overview of attention for article published in Frontiers in oncology, August 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Dimensions has found 1 citation of this research output.

The most recent citing publication is shown below. View this citation on Dimensions.

Article in Reactions Weekly (December 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.